Curcumol Inhibits the Progression of Hepatocellular Carcinoma by Regulating the Expression of hsa_circ_0028861

Yinbing Wu,Huafei Tang,Quanxing Liao,Yinuo Tu,Shuxian Fang,Jinfu He,Shuzhong Cui

DOI: https://doi.org/10.1089/cbr.2023.0061

2024-01-06

Cancer Biotherapy & Radiopharmaceuticals

Abstract:Background: Hsa_circ_0028861 , a newly discovered serum exosome circular RNA (circRNA), is greatly reduced in the serum of patients with hepatocellular carcinoma (HCC). However, the exact role of hsa_circ_0028861 in the progression of liver cancer is still unknown. Materials and Methods: Thirty patients with HCC were enrolled in this study. Hsa_circ_0028861 expression was explored via real-time polymerase chain reaction (PCR) assay. The influences of curcumol on HCC cells were tested using CCK-8 assay, 5-ethynyl-2′-deoxyuridine (EdU) staining, cell wound healing assay, and migration assay, respectively. The related mechanism was determined by Western blot. A xenograft tumor model was constructed, and mice were administrated with curcumol. Results: The hsa_circ_0028861 expression was increased in tumor tissues of patients with HCC and in HCC cells. Curcumol treatment decreased the expression of hsa_circ_0028861 in HCC cells. Curcumol treatment could largely suppress the viability, proliferation, and migration of HCC cells by reducing the hsa_circ_0028861 expression and mediating the epithelial–mesenchymal transition (EMT) process. Curcumol also effectively restrained tumor growth in the HCC mice model. Conclusions: Curcumol exerted an inhibitory role in HCC progression by downregulating the hsa_circ_0028861 expression and mediating the EMT process, which provides evidence for screening new therapeutic targets and drug therapies for HCC treatment.

oncology,pharmacology & pharmacy,radiology, nuclear medicine & medical imaging,medicine, research & experimental